Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

BACKGROUND: The objective of this study was to evaluate the efficacy and toxicity of infusional 5-fluorouracil (5-FU), folinic acid and oxaliplatin (modified FOLFOX-6) in patients with advanced gastric cancer (AGC), as first-line palliative combination chemotherapy. We also analyzed the predictive o...

Descripción completa

Detalles Bibliográficos
Autores principales: Keam, Bhumsuk, Im, Seock-Ah, Han, Sae-Won, Ham, Hye Seon, Kim, Min A, Oh, Do-Youn, Lee, Se-Hoon, Kim, Jee Hyun, Kim, Dong-Wan, Kim, Tae-You, Heo, Dae Seog, Kim, Woo Ho, Bang, Yung-Jue
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442115/
https://www.ncbi.nlm.nih.gov/pubmed/18505590
http://dx.doi.org/10.1186/1471-2407-8-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442115/
https://www.ncbi.nlm.nih.gov/pubmed/18505590
http://dx.doi.org/10.1186/1471-2407-8-148

Ejemplares similares